Results overview: Found 9 records in 0.01 seconds.
Articles, 9 records found
Articles 9 records found  
1.
12 p, 804.5 KB RIC versus MAC UCBT in adults with AML : A report from Eurocord, the ALWP and the CTIWP of the EBMT / Baron, Frédéric (University of Liege) ; Ruggeri, Annalisa (Hôpital Saint-Antoine) ; Beohou, Eric (Hospital Saint Antoine) ; Labopin, Myriam (Hospital Saint Antoine) ; Sanz, Guillermo (Hospital Universitari i Politècnic La Fe (València)) ; Milpied, Noel (University of Bordeaux) ; Michallet, Mauricette (Centre Hospitalier de Lyon Sud) ; Bacigalupo, Andrea (Ospedale San Martino) ; Blaise, Didier (Aix-Marseille Université) ; Malouf Sierra, Jorge 1971- (Institut d'Investigació Biomèdica Sant Pau) ; Socié, Gérard (Hospital Saint-Louis) ; Cornelissen, Jan J. (Erasmus Medical Center-Daniel den Hoed Cancer Center) ; Schmid, Christoph (University of Munich) ; Giebel, Sebastian (Gliwice Branch) ; Gorin, Norbert-Claude (Hospital Saint Antoine) ; Esteve, Jordi (Hematology. Hospital Clinic) ; Ciceri, Fabio (Ospedale San Raffaele) ; Savani, Bipin N. (Vanderbilt University Medical Center) ; Mohty, Mohamad (UMRs 938) ; Gluckman, Eliane (Centre Scientifique de Monaco) ; Nagler, Arnon (The Chaim Sheba Medical Center) ; Universitat Autònoma de Barcelona
Nonrelapse mortality (NRM) is the first cause of treatment failure after unrelated cord blood transplantation (UCBT) following myeloablative conditioning (MAC). In the last decade, reduced-intensity conditioning (RIC) regimens have been developed with the aim of reducing NRM and allowing older patients and those with medical comorbidities to benefit from UCBT. [...]
2016 - 10.18632/oncotarget.9599
Oncotarget, Vol. 7 Núm. 28 (2016) , p. 43027-43038  
2.
10 p, 786.4 KB Haploidentical transplantation is associated with better overall survival when compared to single cord blood transplantation : An EBMT-Eurocord study of acute leukemia patients conditioned with thiotepa, busulfan, and fludarabine / Giannotti, Federica (Saint-Antoine Hospital) ; Labopin, Myriam (Hôpital Saint-Antoine (Paris, França)) ; Shouval, Roni (Chaim Sheba Medical Center (Israel)) ; Sanz, Jaime (Instituto de Salud Carlos III) ; Arcese, William (Rome Transplant Network tor Vergatä) ; Angelucci, Emanuele (Ospedale Policlinico San Martino) ; Malouf Sierra, Jorge 1971- (Institut d'Investigació Biomèdica Sant Pau) ; Ribera, Jose-Maria (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Santarone, Stella (Ospedale Civile) ; Benedetto, Bruno (S.S.C.V.D Trapianto di Cellule Staminali A.O.U Citta della Salute e della Scienza di Torino) ; Rambaldi, Alessandro (Azienda Ospedaliera Papa Giovanni XXIII) ; Saccardi, Riccardo (Azienda Ospedaliera Universitaria Careggi) ; Blaise, Didier (Institut Paoli Calmettes) ; Carella, Michele Angelo (IRCCS) ; Rocha, Vanderson (Universidade de São Paulo) ; Baron, Frederic (University of Liege) ; Mohty, Mohamad (Hospital Saint- Antoine) ; Ruggeri, Annalisa (Ospedale Pediatrico Bambino Gesù (Roma, Itàlia)) ; Nagler, Arnon (Tel-Aviv University) ; Universitat Autònoma de Barcelona
Thiotepa-busulfan-fludarabine (TBF) is a widely used conditioning regimen in single umbilical cord blood transplantation (SUCBT). More recently, it was introduced in the setting of non-T cell depleted haploidentical stem cell transplantation (NTD-Haplo). [...]
2018 - 10.1186/s13045-018-0655-8
Journal of hematology & oncology, Vol. 11 Núm. 1 (30 2018) , p. 110  
3.
6 p, 657.1 KB Outcomes of Advanced Hodgkin Lymphoma after Umbilical Cord Blood Transplantation : A Eurocord and EBMT Lymphoma and Cellular Therapy & Immunobiology Working Party Study / Paviglianiti, Annalisa (Centre Scientifique de Monaco) ; Tozatto Maio, Karina (Centre Scientifique de Monaco) ; Rocha, Vanderson (Hospital Sao Paulo) ; Gehlkopf, Eve (CHU Lapeyronie) ; Milpied, Noel (CHU Bordeaux) ; Esquirol, Albert (Institut d'Investigació Biomèdica Sant Pau) ; Chevallier, Patrice (Hospital Hotel Dieu (Nantes, França)) ; Blaise, Didier (Institute Paoli Calmettes) ; Gac, Anne-Claire (Institut d'Hématologie de Basse-Normandie) ; Leblond, Véronique (Hopital la Pitié-Salpêtrière) ; Cahn, Jean-Yves (CHU Grenoble Alpes) ; Abecasis, Manuel (Institute Portugues Oncologia) ; Zuckerman, Tsila (Rambam Medical Center) ; Schouten, Harry (University Hospital Maastricht) ; Gurman, Gunhan (Ankara University) ; Rubio, Marie Thérèse (Hôpitaux des Brabois) ; Beguin, Yves (CHU of Liège and University of Liege) ; Corral, Lucia Lopez (Centro de Investigacion del Cancer-IBMCC) ; Nagler, Amon (Chaim Sheba Medical Center (Israel)) ; Snowden, John A. (Sheffield Teaching Hospitals NHS Trust) ; Koc, Yener (Stem Cell Transplant Unit Medical Park Hospitals) ; Mordini, Nicola (Az. Ospedaliera S. Croce e Carle) ; Bonifazi, Francesca ("Seragnoli" University Hospital S. Orsola-Malpighi) ; Volt, Fernanda (Centre Scientifique de Monaco) ; Kenzey, Chantal (Centre Scientifique de Monaco) ; Robinson, Stephen Paul (EBMT Lymphoma Working Party) ; Montoto, Silvia (EBMT Lymphoma Working Party) ; Gluckman, Eliane (Centre Scientifique de Monaco) ; Ruggeri, Annalisa (Bambin Gesù) ; Universitat Autònoma de Barcelona
Allogeneic stem cell transplantation is an alternative for patients with relapsed or refractory Hodgkin lymphoma (HL), but only limited data on unrelated umbilical cord blood transplantation (UCBT) are available. [...]
2018 - 10.1016/j.bbmt.2018.07.019
Biology of Blood and Marrow Transplantation, Vol. 24 Núm. 11 (november 2018) , p. 2265-2270  
4.
7 p, 530.8 KB Reduced-Intensity versus Myeloablative Conditioning in Cord Blood Transplantation for Acute Myeloid Leukemia (40-60 years) across Highly Mismatched HLA Barriers-On Behalf of Eurocord and the Cellular Therapy & Immunobiology Working Party (CTIWP) of EBMT / Sheth, V. (Fred Hutchison Cancer Research Centre) ; Volt, F. (Eurocord) ; Sanz, J. (Hospital Universitari i Politècnic La Fe (València)) ; Clement, L. (Haut-Lévêque) ; Cornelissen, J. (Erasmus MC-Daniel den Hoed Cancer Centre) ; Blaise, Didier (Paoli Calmettes) ; Malouf Sierra, Jorge 1971- (Institut d'Investigació Biomèdica Sant Pau) ; Michallet, M. (Centre Leon Berard) ; Saccardi, R. (Azienda Ospedaliero Universitaria Meyer-Ospedale di Careggi) ; Rocha, V. (Eurocord) ; Gluckman, E. (Eurocord) ; Chabannon, C. (Institut Paoli-Calmettes) ; Ruggeri, Annalisa (IRCCS San Raffaele Scientific Institute (Milà, Itàlia)) ; Universitat Autònoma de Barcelona
The use of myeloablative conditioning (MAC) in umbilical cord blood transplantation (UCBT) has been associated with high nonrelapse mortality (NRM) in patients aged >40 years, especially those having a high HLA disparity, thus limiting wider applications. [...]
2020 - 10.1016/j.bbmt.2020.07.025
Biology of Blood and Marrow Transplantation, Vol. 26 Núm. 11 (november 2020) , p. 2098-2104  
5.
11 p, 340.8 KB Outcomes of subsequent neoplasms after umbilical cord blood transplantation in Europe / Rafii, Hanadi (Centre Scientifique de Monaco) ; Ruggeri, Annalisa (IRCCS San Raffaele Scientific Institute (Milan, Itàlia)) ; Kenzey, Chantal (Centre Scientifique de Monaco) ; Sanz, Jaime (Hospital Universitari i Politècnic La Fe (València)) ; Peffault De La Tour, Régis (Assistance Publique-Hôpitaux de Paris) ; Esquirol, Albert (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Michel, Gérard (Hopital pédiatrique de la Timone (Marseille, França)) ; Chevallier, Patrice (Hospital Hotel Dieu (Nantes, França)) ; Rubio, Marie-Thérèse (CHRU Nancy (Nancy, França)) ; Cornelissen, Jan J. (Erasmus MC-Daniel den Hoed Cancer Centre) ; Michallet, Mauricette (Centre Leon Berard) ; Volt, Fernanda (Monacord, Centre Scientifique de Monaco) ; Rivera-Franco, Monica M. (Centre Scientifique de Monaco) ; Scigliuolo, Graziana Maria (Centre Scientifique de Monaco) ; Cappelli, Barbara (Centre Scientifique de Monaco) ; Rocha, Vanderson (São Paulo Medical School) ; Gluckman, Eliane (Centre Scientifique de Monaco) ; Universitat Autònoma de Barcelona
Subsequent neoplasms (SNs) compromise long-term survivors after hematopoietic cell transplantation. We performed a retrospective analysis of SNs in 10 358 recipients of umbilical cord blood transplantation (UCBT) from 1988 to 2018. [...]
2022 - 10.1182/bloodadvances.2022007941
Blood advances, Vol. 7 (november 2022) , p. 1976-1986  
6.
8 p, 1.8 MB Benchmarking of survival outcomes following Haematopoietic Stem Cell Transplantation (HSCT) : an update of the ongoing project of the European Society for Blood and Marrow Transplantation (EBMT) and Joint Accreditation Committee of ISCT and EBMT (JACIE) / Saccardi, Riccardo (Careggi University Hospital (Florència, Itàlia)) ; Putter, Hein (Leiden University Medical Center) ; Eikema, Dirk-Jan (EBMT Statistical Unit Leiden) ; Busto, María Paula (EBMT Registry) ; McGrath, Eoin (ICCBBA (Barcelona, Espanya)) ; Middelkoop, Bas (European Society for Blood and Marrow Transplantation-EBMT Registry) ; Adams, Gillian (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ; Atlija, Marina (European Society for Blood and Marrow Transplantation-EBMT Registry) ; Ayuk, Francis Ayuketang (University Medical Center Hamburg) ; Baldomero, Helen (University Hospital Basel (Basilea, Suïssa)) ; Beguin, Yves (CHU of Liège and University of Liège) ; de la Camara, Rafael (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ; Cedillo Cedillo, Angel (Grupo Español de Trasplantes Hematopoyéticos y Terapia Celular) ; Balari, Anna María Sureda (Hospital Universitari de Bellvitge) ; Chabannon, Christian (Institut Paoli-Calmettes Comprehensive Cancer Centre) ; Corbacioglu, Selim (University Children's Hospital Regensburg) ; Dolstra, Harry (Radboud University Medical Center) ; Duarte, Rafael (Universidad Autónoma de Madrid) ; Duléry, Rémy (Sorbonne Université) ; Greco, Raffaella (Autoimmune Diseases Working Party (Barcelona, Espanya)) ; Gusi, Andreu (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ; Hamad, Nada (University of Notre Dame Australia) ; Kenyon, Michelle (King's College Hospital NHS Foundation Trust) ; Kroeger, Nicolaus (University Medical Center Hamburg) ; Labopin, Myriam (European Society for Blood and Marrow Transplantation-EBMT Paris Study Office) ; Lee, Julia (British Society of Blood and Marrow Transplantation and Cellular Therapy (Regne Unit)) ; Ljungman, Per (Karolinska University Hospital and Karolinska Institutet (Suècia)) ; Manson, Lynn (Edinburgh & SE Scotland Clinical Transfusion Centre Patient Services (Regne Unit)) ; Mensil, Florence (Agence de la Biomédecine) ; Milpied, Noel (Centre Hospitalier Universitaire Bordeaux) ; Mohty, Mohamad (Sorbonne University) ; Oldani, Elena (Italian National BMT Registry) ; Orchard, Kim (University Hospital Southampton NHS) ; Passweg, Jakob (University Hospital Basel (Basilea, Suïssa)) ; Pearce, Rachel (British Society of Blood and Marrow Transplantation and Cellular Therapy (Regne Unit)) ; de Latour, Régis Peffault (BMT unit Paris Cité University) ; Poirel, Hélène A. (Belgian Transplant Registry) ; Rintala, Tuula (King's College Hospital NHS Foundation Trust) ; Rizzo, J. Douglas (CIBMTR, Medical College of Wisconsin) ; Ruggeri, Annalisa (IRCCS San Raffaele Scientific Institute (Milà, Itàlia)) ; Sanchez-Martinez, Carla (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ; Sanchez-Guijo, Fermin (CIC-University of Salamanca) ; Sánchez-Ortega, Isabel (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ; Trnková, Marie (Czech registry Czech Republic) ; Valcárcel, David (Vall d'Hebron Institut d'Oncologia) ; Wilcox, Leonie (Australasian Bone Marrow Transplant Recipient Registry) ; de Wreede, Liesbeth C. (Leiden University Medical Center) ; Snowden, John A. (Sheffield Teaching Hospitals NHS Foundation Trust (Sheffield, Regne Unit)) ; Universitat Autònoma de Barcelona
From 2016 EBMT and JACIE developed an international risk-adapted benchmarking program of haematopoietic stem cell transplant (HSCT) outcome to provide individual EBMT Centers with a means of quality-assuring the HSCT process and meeting FACT-JACIE accreditation requirements relating to 1-year survival outcomes. [...]
2023 - 10.1038/s41409-023-01924-6
Bone marrow transplantation, march 2023, p. 1-8  
7.
11 p, 2.6 MB Development of adaptive immune effector therapies in solid tumors / Comoli, P. (Cell Factory and Pediatric Hematology Oncology. Fondazione IRCCS Policlinico San Matteo) ; Chabannon, Christian (Institut Paoli-Calmettes. Aix-Marseille University. INSERM CBT 1409. Centre for Clinical Investigation in Biotherapy) ; Koehl, U. (Institute of Cellular Therapeutics. Hannover Medical School) ; Lanza, F. (Hematology and Stem Cell Transplant. Romagna Transplant Network) ; Urbano Ispizua, Álvaro (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Hudecek, M. (University Hospital Würzburg) ; Ruggeri, Annalisa (Ospedale Pediatrico Bambino Gesù (Roma, Itàlia)) ; Secondino, S. (Università degli Studi di Pavia. Dipartimento di Medicina Interna e Terapia Medica) ; Bonini, C. (University Vita-Salute San Raffaele) ; Pedrazzoli, P. (Università degli Studi di Pavia. Dipartimento di Medicina Interna e Terapia Medica) ; Universitat Autònoma de Barcelona
State-of-the-art treatment strategies have drastically ameliorated the outcome of patients affected by cancer. However, resistant and recurrent solid tumors are generally nonresponsive to conventional therapies. [...]
2019 - 10.1093/annonc/mdz285
Annals of oncology, Vol. 30 Núm. 11 (november 2019) , p. 1740-1750  
8.
13 p, 1.0 MB Post-transplant cyclophosphamide after matched sibling, unrelated and haploidentical donor transplants in patients with acute myeloid leukemia : A comparative study of the ALWP EBMT / Sanz, Jaime (Centro de Investigación Biomédica en Red de Cáncer) ; Galimard, J. E. (EBMT Paris Office. Hospital Saint Antoine) ; Labopin, Myriam (Department of Hematology. Hopital Saint Antoine. Sorbonne University) ; Afanasyev, B. (First State Pavlov Medical University of St. Petersburg. Raisa Gorbacheva Mem. Research Institute for Paediatric Oncology. Hematology. and Transplantation) ; Angelucci, E. (Department of Haematology. IRCCS Ospedale Policlinico San Martino) ; Ciceri, Fabio (Haematology and BMT) ; Blaise, Didier (Programme de Transplantation and Therapie Cellulaire. Centre de Recherche en Cancérologie de Marseille. Institut Paoli Calmettes) ; Cornelissen, J. J. (Department of Hematology. Erasmus MC Cancer Institute. University Medical Center Rotterdam) ; Meijer, E. (Department of Hematology (Br 250). VU University Medical Center) ; Diez-Martin, J. L. (Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM)) ; Koc, Y. (Stem Cell Transplant Unit. Medical Park Hospitals) ; Rovira Tarrats, Montserrat (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Castagna, L. (Transplantation Unit. Department of Oncology and Haematology. Istituto Clinico Humanitas) ; Savani, B. N. (Vanderbilt University Medical Center) ; Ruggeri, Annalisa (Ospedale Pediatrico Bambino Gesù (Roma, Itàlia)) ; Nagler, Arnon (ALWP of the EBMT Office. Saint Antoine Hospital) ; Mohty, Mohamad (Department of Hematology. Hopital Saint Antoine. Sorbonne University) ; Universitat Autònoma de Barcelona
Background: The use of post-transplant cyclophosphamide (PTCy) is highly effective in preventing graft-versus-host disease (GVHD) in the haploidentical (Haplo) transplant setting and is being increasingly used in matched sibling (MSD) and matched unrelated (MUD) transplants. [...]
2020 - 10.1186/s13045-020-00882-6
Journal of hematology & oncology, Vol. 13 Núm. 1 (june 2020) , p. 46  
9.
11 p, 858.6 KB Unrelated cord blood transplantation for adult patients with acute myeloid leukemia: higher incidence of acute graft-versus-host disease and lower survival in male patients transplanted with female unrelated cord blood--a report from Eurocord, the Acute Leukemia Working Party, and the Cord Blood Committee of the Cellular Therapy and Immunobiology Working Party of the European Group for Blood and Marrow Transplantation / Baron, Frederic (Université de Liège (Bèlgica)) ; Labopin, Myriam (Hôpital Saint-Antoine (Paris, França)) ; Ruggeri, Annalisa (Hôpital Saint-Louis (Paris, França)) ; Mohty, Mohamad (Hôpital Saint-Antoine (Paris, França)) ; Sanz, Guillermo (Hospital Universitari i Politècnic La Fe (València)) ; Milpied, Noel (Hôpital Haut Léveque (Pessac, França)) ; Bacigalupo, Andrea (Ospedale Sant Martino (Genova, Itàlia)) ; Rambaldi, Alessandro (Azienda Ospedaliera Papa Giovanni XXIII (Bergamo, Itàlia)) ; Bonifazi, Francesca (Policlinico Sant'Orsola-Malpighi (Bologna, Itàlia)) ; Bosi, Alberto (Azienda Ospedaliero Universitaria Careggi (Firenze, Itàlia)) ; Sierra, Jorge (Institut d'Investigació Biomèdica Sant Pau) ; Yakoub-Agha, Ibrahim (Hôpital Claude Huriez (Lille, França)) ; Ribera, Jose-Maria (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Gluckman, Eliane (Hôpital Saint-Louis (Paris, França)) ; Nagler, Arnon (Sheba Medical Center (Ramat Gran, Israel)) ; Universitat Autònoma de Barcelona
BACKGROUND: In the setting of allogeneic human leukocyte antigen (HLA)-matched bone marrow transplantation, transplanting male patients with grafts from female donors has been associated with a higher incidence of graft-versus-host disease (GVHD) and of nonrelapse mortality (NRM). [...]
2015 - 10.1186/s13045-015-0207-4
Journal of hematology & oncology, Vol. 8 Núm. 107 (october 2015)  

See also: similar author names
1 Ruggeri, A.
5 Ruggeri, A.C.
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.